MedTrace Logo

Effects of ACT-Based Psychoeducation on Caregivers of Individuals With Mental Disorders

NCT07643714 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-06-11

No results posted yet for this study

Summary

This randomized controlled trial aimed to examine the effects of Acceptance and Commitment Therapy (ACT)-based psychoeducation program on psychological resilience, stress management, and caregiver burden in caregivers of individuals with mental disorders. Participants were randomly assigned to either the intervention or control group. The intervention group received ACT-based psychoeducation while the control group received no intervention.

H1-1: The mean psychological resilience scores of caregivers in the intervention group who received the ACT-based psychoeducation program are significantly higher compared to caregivers in the control group.

H1-2: The mean stress management scores of caregivers in the intervention group who received the ACT-based psychoeducation program are significantly higher compared to caregivers in the control group.

H1-3: The mean caregiver burden scores of caregivers in the intervention group who received the ACT-based psychoeducation program are significantly lower compared to caregivers in the control group.

H1-4: The effects of the ACT-based psychoeducation program on psychological resilience, stress management, and caregiver burden differ significantly between caregivers of individuals diagnosed with schizophrenia and caregivers of individuals diagnosed with bipolar disorder.

Conditions

  • Caregiver Burden
  • Mental Disorders

Interventions

BEHAVIORAL

ACT-Based Psychoeducation Program

ACT-based psychoeducation program delivered to caregivers of individuals with mental disorders (schizophrenia and bipolar disorder). The program was based on Acceptance and Commitment Therapy principles and consisted of 8 sessions. It aimed to improve psychological resilience, stress management, and reduce caregiver burden. Sessions were conducted in group format.

Sponsors & Collaborators

  • Zeynep Özkök

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-06
Primary Completion
2025-11-24
Completion
2026-01-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07643714 on ClinicalTrials.gov